Innocoll - collaguard - a collagen-based advanced wound care product
Health is a unity and harmony within the mind, body and spirit which is unique to each person, and is as defined by that person. The level of wellness or health is, in part, determined by the ability to deal with and defend against stress. Health is determined by physiological, psychological, socio-cultural, spiritual, and developmental stage variables.
logo - spiritindia - Innocoll - collaguard - a collagen-based advanced wound care product
Home | Cancer | Therapies | Diet | Herbs | Heart | Skin | Cosmetic Surgery | Arthritis | Allergies | Eyes | GIT

Innocoll - collaguard - a collagen-based advanced wound care product

Health :: Innocoll - collaguard - a collagen-based advanced wound care product

Health :: Innocoll - collaguard - a collagen-based advanced wound care product

Innocoll, Inc. announced that its wholly-owned subsidiary, Innocoll Pharmaceuticals, has received US 510k approval for CollaGUARD(TM), an advanced wound care product based on Innocoll's proprietary CollaRx(TM) membrane technology. CollaGUARD is indicated for the management of superficial and deep wounds, including coverage of skin ulcers and temporary dermatoplasty in the case of lesion and burns. CollaGUARD has already received CE-mark approval for marketing in Europe.

CollaGUARD is comprised almost entirely of purified type-I collagen protein. Unlike alginates, hydrogels and hydrocolloids used in other categories of advanced wound care products, collagen is a fully biodegradable and bioactive material with a pharmacological action that stimulates the natural wound healing process. In addition, CollaGUARD provides the barrier protection and transparency of film dressings, which allows the clinician to visually inspect and monitor the wound without removal.

The worldwide market for advanced wound care dressings is worth well in excess of $1 billion. In the past, collagen-based dressings have dominated the premium priced market with the so-called "artificial skins" (collagen membranes incorporating living cells) or "synthetic skin substitutes" made of complex composite layers. Other products are based upon lyophilized collagen sponges, a relatively slow and expensive manufacturing process. By contrast, CollaGUARD, can be manufactured using a streamlined, cost-effective production process.

CollaGUARD is the lead product in Innocoll's advanced wound care portfolio. Follow-up products currently in development include CollaGUARD Ag (a collagen-based bioactive dressing impregnated with silver for infected wounds or wounds at risk of infection) and DermaSIL(TM) (a patented collagen- synthetic foam composite dressing for deep and heavily exuding wounds). Innocoll expects to file US 510k and European CE-mark registrations for both CollaGUARD Ag and DermaSIL in 2007.

Dr. Michael Myers, President and CEO commented, "This is an important milestone for Innocoll, as it marks our first regulatory approval in the US. Products based upon the CollaRx membrane technology such as CollaGUARD can be manufactured by a highly efficient and cost-effective process, which will allow us to compete very favourably against other collagen-based wound care products."

About CollaRx

CollaRx is Innocoll Technologies' lead technology platform for the site specific targeted delivery of a wide variety of medicines with particular emphasis on antibiotics and anesthetics. The CollaRx technology also forms the basis of Innocoll Pharmaceuticals' lead product, Gentamicin Surgical Implant, a biodegradable leave-behind implant indicated for the treatment and prevention of post-surgical acquired infection in both hard and soft tissues.

About Innocoll, Inc.

Innocoll is a privately held, fully integrated, global, hospital specialty pharmaceutical company specializing in surgical and dermatological products. It develops and markets internationally a range of medical products using its proprietary collagen-based technologies, CollaRx(TM) and LiquiColl(R). Innocoll, Inc. acquired the product rights for Gentamicin Surgical Implant from Essex Chemis AG, an affiliated company of Schering-Plough Corporation (NYSE: SGP) and has since assumed all sales, marketing and distribution activities for the product.

(Health :: Innocoll - collaguard - a collagen-based advanced wound care product published at SpiritIndia on Monday, October 16, 2006)

Search more information on Health

Recently posted related articles on Health :

  1. Health :: First aid for family health and homoeopathy
  2. Health :: Number of cases of most vaccine-preventable diseases in US at all-time low
  3. Health :: UN-backed fund to fight major diseases approves $1.1 billion of new grants
  4. Smoking :: Smokers remain unaware of the health effects of smoking
  5. Health :: Why poor kids may make sicker adults
  6. Health Care :: Survey finds one-third of US adults call for completely rebuilding the health care system
  7. Health :: Research sheds new light on how diseases jump across species
  8. Psychology :: Child health psychologists need to promote adult disease prevention
  9. Stress :: Stress on the rise, affecting health, relationships and work
  10. Health Insurance :: Private/public insurance mix is most practical way to achieve universal coverage

»»   Neuroma :: Anesiva - orphan drug status for pain drug 4975 to treat interdigital neuroma
««   Imaging :: Tripath imaging receives fda 510(k) clearance for p53 application for ventana image analysis system

Tools
Daily calorie need
Homeo tips
Homeo softwares
Associations
NHMC Alumni
IFH
PHS
Vital Informer
Articles & news
Education
Homeo articles
Homeopathy cases
Homeopathic Remedies
You
Authors
Submit article
Your account
Testimonials
About
About us
Advertisers
Advertising
Linking us
Disclaimer
Privacy policy

The information provided on SpiritIndia.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. We comply with the HONcode principles for trustworthy health information.
Health, Business, Science, Sports, Entertainment, Technology
©2002-2009 SpiritIndia.com